Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erfukang Ointment for Pediatric Subacute Eczema (Wind‑Heat Pattern)
CTR20131295Phase 2Active
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Erfukang in atopic dermatitis (AD), urticaria, miliaria. Started Nov 2013; status: active.
02
Drugs
Erfukang
03
Conditions
atopic dermatitis (AD)urticariamiliaria
Beyond the preview
Go deeper on CTR20131295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131295.